产品和服务 / 产品类型 / ELISA试剂盒 / ELISA 抗体对

Rabbit anti-Human Hyaluronidase 1/HYAL1 mAb(DET) (RMK0008)

This standard curve is only for demonstration purposes. A standard curve should be generated for each assay.

This standard curve is only for demonstration purposes. A standard curve should be generated for each assay.

All(2)|
货号: RMK0008
促销价:   ¥2100
抗体定制服务咨询 |
扫码下单
享受积分

详细信息

产品名称
Rabbit anti-Human Hyaluronidase 1/HYAL1 mAb(DET)
货号
RMK0008
免疫原
Recombinant Human Hyaluronidase 1/HYAL1
纯化方式
Affinity purification
同种型
Rabbit IgG
存储溶液
Supplied as a 0.2um filtered solution in PBS with 0.05%ProClin 300,PH 7.4.
存储条件
Store at -20℃. Avoid freeze / thaw cycles. Preservative:0.05%ProClin 300.Avoid repeated freeze-thaw cycles.

* This package insert must be read in its entirety before using this product.

应用

Human Hyaluronidase 1/HYAL1 Multiplex/ELISA

  Recommended
Concentration
Sample
MultiplexCapture3-20ug/mLRabbit anti-Human Hyaluronidase 1/HYAL1 mAb(Cat. No.RMK0447)
Detection0.017-2ug/mLRabbit anti-Human Hyaluronidase 1/HYAL1 mAb(Cat. No.RMK0008)
Standard6.86-5000pg/mLRecombinant Human Hyaluronidase 1/HYAL1
ELISACapture1-4ug/mLRabbit anti- Human Hyaluronidase 1(Cat. No.RMK0007)
Detection0.01-0.0025ug/mLRabbit anti- Human Hyaluronidase 1(Cat. No.RMK0008)
Standard0.15-10ng/mLRecombinant Human Hyaluronidase 1

背景信息

Troponin I (TnI), along with troponin T (TnT) and troponin C (TnC), is one of 3 subunits that form the troponin complex of the thin filaments of striated muscle. TnI is the inhibitory subunit; blocking actin-myosin interactions and thereby mediating striated muscle relaxation. The TnI subfamily contains three genes: TnI-skeletal-fast-twitch, TnI-skeletal-slow-twitch, and TnI-cardiac. This gene encodes the TnI-cardiac protein and is exclusively expressed in cardiac muscle tissues. Mutations in this gene cause familial hypertrophic cardiomyopathy type 7 (CMH7) and familial restrictive cardiomyopathy (RCM). Troponin I is useful in making a diagnosis of heart failure, and of ischemic heart disease. An elevated level of troponin is also now used as indicator of acute myocardial injury in patients hospitalized with moderate/severe Coronavirus Disease 2019 (COVID-19). Such elevation has also been associated with higher risk of mortality in cardiovascular disease patients hospitalized due to COVID-19.

>